Bacteriology and management of necrotizing soft tissue infections.
Abbott
Iain J
IJ
Spelman
Denis
D
D002981:Clindamycin / Q000627:therapeutic use; D003015:Clostridium Infections / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy; D003014:Clostridium botulinum / Q000472:pathogenicity; D003016:Clostridium perfringens / Q000472:pathogenicity; D047989:Paraclostridium sordellii / Q000472:pathogenicity*; D003017:Clostridium tetani / Q000472:pathogenicity; D017714:Community-Acquired Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology; D004636:Emergency Service, Hospital; D019115:Fasciitis, Necrotizing / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D011859:Radiography; D018461:Soft Tissue Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D015819:Substance Abuse, Intravenous / Q000382:microbiology*
D016756:Immunoglobulins, Intravenous; D002981:Clindamycin